Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours

Johann de Bono, Chia Chi Lin, Li Tzong Chen, Jesus Corral, Vasiliki Michalarea, Karim Rihawi, Michael Ong, Jih Hsiang Lee, Chih Hung Hsu, James Chih Hsin Yang, Her Shyong Shiah, Chia Jui Yen, Alan Anthoney, Maria Jove, Susanne Buschke, René Fuertig, Ulrike Schmid, Rainer Georg Goeldner, Natalja Strelkowa, Dennis Chin Lun HuangThomas Bogenrieder, Chris Twelves, Ann Lii Cheng

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours'. Together they form a unique fingerprint.

Medicine & Life Sciences